Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer
2013 ◽
Vol 8
(5)
◽
pp. e41-e42
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21128-e21128
Keyword(s):
2015 ◽
Keyword(s):
2018 ◽
2017 ◽
Vol 20
(7)
◽
pp. 881-888
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 87
◽
pp. 107288
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8565-8565
◽
Keyword(s):